Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0206-2027

Techno-Path Multichem AE Unassayed Level 2 REF: AE622X Recall

Techno-Path Multichem AE Unassayed Level 2 REF: AE622X

FDA recall Class II

Ongoing

FDA lists this Class II recall for Techno-Path Multichem AE Unassayed Level 2 REF: AE622X. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0206-2027
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Aug 14, 2026
FDA report date
Oct 28, 2026
Quantity in commerce
123 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Techno-Path Multichem AE Unassayed Level 2 REF: AE622X

Affected model & UDI checker

Search the exact identifiers published for Z-0206-2027.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
AE622XTechno-Path Multichem AE Unassayed Level 2 REF: AE622XCheck source noticeNot specified
FDA code information

UDI:(01)05391523442817/Lot # 65705262

View the original FDA recall notice

Why was this product recalled?

A routine stability studies have identified a stability drift affecting the Ammonia (NH4+) analyte in specific lots of Multichem AE quality control material. Additional testing confirmed that the labelled shelf-life performance claim for the Ammonia analyte can no longer be supported for the affected lots. This issue is limited to the Ammonia analyte only. The impacted device may cause delay of issuing results to the physician. Delayed recognition and diagnosis of elevated levels may impact in timely treatment of life-threatening levels described within medical toxicity intervention decision points.

What actions did TECHNO-PATH MANUFACTURING LTD. take?

On August 14, 2026, Techno Path Manufacturing Ltd has issued a medical device correction to consignees via email. Techno Path Manufacturing Ltd informed consignees to please verify their inventory against the affected product codes and lot numbers. Techno Path Manufacturing Ltd. has informed the consignees to take the following actions: 1. Immediately place all affected inventory on hold and prevent further distribution. 2. Quarantine all affected product currently under your control. 3. Confirm that there has been no distribution of the impacted lots to customers. 4. Confirm receipt of this notification and provide inventory and distribution details to Technopath Manufacturing Ltd. within 3 business days. 5. Arrange return or destruction of affected inventory in accordance with instructions provided by Technopath Manufacturing Ltd.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology